Ohio Hematopoietic Transplant And Cellular Therapy Consortium
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 119,724 | 95,917 | 23,807 | 11.2 | 0% |
| 2012 | 117,153 | 75,113 | 42,040 | 21.0 | 0% |
| 2013 | 117,679 | 102,184 | 15,495 | 17.3 | 0% |
| 2014 | 115,380 | 103,281 | 12,099 | 19.0 | 0% |
| 2015 | 145,923 | 102,611 | 43,312 | 24.2 | 0% |
| 2016 | 143,323 | 101,085 | 42,238 | 29.6 | 0% |
| 2017 | 100,385 | 101,737 | −1,352 | 21.4 | 0% |
| 2018 | 102,574 | 83,763 | 18,811 | 27.7 | 0% |
| 2019 | 106,798 | 102,793 | 4,005 | 23.0 | 0% |
| 2020 | 76,902 | 82,852 | −5,950 | 29.6 | 0% |
| 2021 | 79,026 | 72,060 | 6,966 | 35.2 | 0% |
| 2022 | 105,149 | 82,574 | 22,575 | 32.0 | 0% |
| 2023 | 99,377 | 131,258 | −31,881 | 20.0 | 0% |
In its most recent public year (2023), this organization spent $31,881 more than it brought in. Its reserves stood at about 20 months of spending, up from 11.2 in 2011. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Ohio Hematopoietic Transplant And Cellular Therapy Consortium's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works